| Endometrial carcinoma: molecular alterations involved in tumor development and progression A Yeramian, G Moreno-Bueno, X Dolcet, L Catasus, M Abal, E Colas, ... Oncogene 32 (4), 403-413, 2013 | 222 | 2013 |
| Molecular pathology of endometrial carcinoma: practical aspects from the diagnostic and therapeutic viewpoints D Llobet, J Pallarés, A Yeramian, M Santacana, N Eritja, A Velasco, ... Journal of clinical pathology 62 (9), 777-785, 2009 | 217 | 2009 |
| Arginine transport via cationic amino acid transporter 2 plays a critical regulatory role in classical or alternative activation of macrophages A Yeramian, L Martin, N Serrat, L Arpa, C Soler, J Bertran, C McLeod, ... The Journal of Immunology 176 (10), 5918-5924, 2006 | 162 | 2006 |
| Macrophages require distinct arginine catabolism and transport systems for proliferation and for activation A Yeramian, L Martin, L Arpa, J Bertran, C Soler, C McLeod, M Modolell, ... European journal of immunology 36 (6), 1516-1526, 2006 | 101 | 2006 |
| Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer N Eritja, BJ Chen, R Rodríguez-Barrueco, M Santacana, S Gatius, A Vidal, ... Autophagy 13 (3), 608-624, 2017 | 87 | 2017 |
| Antioxidants block proteasome inhibitor function in endometrial carcinoma cells D Llobet, N Eritja, M Encinas, A Sorolla, A Yeramian, JA Schoenenberger, ... Anti-cancer drugs 19 (2), 115-124, 2008 | 86 | 2008 |
| Inhibition of WNT-CTNNB1 signaling upregulates SQSTM1 and sensitizes glioblastoma cells to autophagy blockers M Nàger, MC Sallán, A Visa, C Pushparaj, M Santacana, A Macià, ... Autophagy 14 (4), 619-636, 2018 | 81 | 2018 |
| A novel three-dimensional culture system of polarized epithelial cells to study endometrial carcinogenesis N Eritja, D Llobet, M Domingo, M Santacana, A Yeramian, X Matias-Guiu, ... The American journal of pathology 176 (6), 2722-2731, 2010 | 79 | 2010 |
| CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells D Llobet, N Eritja, M Encinas, N Llecha, A Yeramian, J Pallares, A Sorolla, ... Oncogene 27 (18), 2513-2524, 2008 | 79 | 2008 |
| Signalling by neurotrophins and hepatocyte growth factor regulates axon morphogenesis by differential β-catenin phosphorylation MD David, A Yeramian, M Duñach, M Llovera, C Cantí, AG de Herreros, ... Journal of cell science 121 (16), 2718-2730, 2008 | 72 | 2008 |
| Deacetylase activity is required for STAT5-dependent GM-CSF functional activity in macrophages and differentiation to dendritic cells C Sebastián, M Serra, A Yeramian, N Serrat, J Lloberas, A Celada The Journal of Immunology 180 (9), 5898-5906, 2008 | 62 | 2008 |
| Endometrial carcinoma: specific targeted pathways N Eritja, A Yeramian, BJ Chen, D Llobet-Navas, E Ortega, E Colas, ... Molecular Genetics of Endometrial Carcinoma, 149-207, 2017 | 61 | 2017 |
| The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms D Llobet, N Eritja, A Yeramian, J Pallares, A Sorolla, M Domingo, ... European Journal of Cancer 46 (4), 836-850, 2010 | 60 | 2010 |
| CK2β is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation J Pallares, D Llobet, M Santacana, N Eritja, A Velasco, D Cuevas, ... The American journal of pathology 174 (1), 287-296, 2009 | 60 | 2009 |
| Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathway A Yeramian, A Sorolla, A Velasco, M Santacana, X Dolcet, J Valls, L Abal, ... International journal of cancer 130 (4), 967-978, 2012 | 56 | 2012 |
| Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma A Velasco, J Pallares, M Santacana, S Gatius, M Fernandez, M Domingo, ... Human pathology 42 (2), 185-193, 2011 | 54 | 2011 |
| Effect of proteasome inhibitors on proliferation and apoptosis of human cutaneous melanoma‐derived cell lines A Sorolla, A Yeramian, X Dolcet, AM Perez de Santos, D Llobet, ... British Journal of Dermatology 158 (3), 496-504, 2008 | 52 | 2008 |
| Arginine transport is impaired in C57Bl/6 mouse macrophages as a result of a deletion in the promoter of Slc7a2 (CAT2), and susceptibility to Leishmania infection is reduced MG Sans-Fons, A Yeramian, S Pereira-Lopes, LF Santamaría-Babi, ... The Journal of infectious diseases 207 (11), 1684-1693, 2013 | 51 | 2013 |
| Nuclear factor-κB2/p100 promotes endometrial carcinoma cell survival under hypoxia in a HIF-1α independent manner A Yeramian, M Santacana, A Sorolla, D Llobet, M Encinas, A Velasco, ... Laboratory investigation 91 (6), 859-871, 2011 | 47 | 2011 |
| Blockade of NFκB activity by sunitinib increases cell death in bortezomib-treated endometrial carcinoma cells A Sorolla, A Yeramian, J Valls, X Dolcet, L Bergadà, A Llombart-Cussac, ... Molecular oncology 6 (5), 530-541, 2012 | 42 | 2012 |
